MedPath

山西昂生药业有限责任公司

Ownership
-
Established
2001-09-10
Employees
-
Market Cap
-
Website
www.ascnyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

84

NMPA:84

Drug Approvals

大风丸

Approval Number
国药准字Z14021936
Approval Date
Aug 17, 2020
NMPA

六味地黄丸

Approval Number
国药准字Z14021937
Approval Date
Aug 17, 2020
NMPA

益心酮片

Approval Number
国药准字Z14020743
Approval Date
Aug 17, 2020
NMPA

Vitamin D2 and Calcium Hydrogen Phosphate Tablets

Product Name
维D2磷酸氢钙片
Approval Number
国药准字H14023870
Approval Date
Aug 17, 2020
NMPA

Compound Bear Gall and Deppermint Buccal Tablets

Product Name
复方熊胆薄荷含片
Approval Number
国药准字H14023869
Approval Date
Aug 17, 2020
NMPA

香砂养胃丸

Approval Number
国药准字Z14021979
Approval Date
Aug 17, 2020
NMPA

牛黄上清丸

Approval Number
国药准字Z14021938
Approval Date
Jul 30, 2020
NMPA

Metamizole Sodium Tablets

Product Name
安乃近片
Approval Number
国药准字H14021557
Approval Date
Jul 30, 2020
NMPA

Paracetamol,Caffeine,Artificial Cow-bezoar and Chlorphenamine Maleate Capsules

Product Name
氨咖黄敏胶囊
Approval Number
国药准字H14023871
Approval Date
Jul 30, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H14021578
Approval Date
Jul 30, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath